Profile
Lynn Gallant worked as Vice President-Clinical Operations at BlueRock Therapeutics Canada ULC and Enveric Biosciences, Inc. Ms. Gallant obtained an undergraduate degree from the University of New England.
Former positions of Lynn Gallant
| Companies | Position | End |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2023-04-30 |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
Training of Lynn Gallant
| University of New England | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Lynn Gallant
